Alpha Teknova (NASDAQ:TKNO) Stock Price Up 1.3%

Alpha Teknova, Inc. (NASDAQ:TKNO)’s share price rose 1.3% during mid-day trading on Thursday . The stock traded as high as $1.95 and last traded at $1.94. Approximately 10,380 shares traded hands during trading, a decline of 27% from the average daily volume of 14,277 shares. The stock had previously closed at $1.91.

Analyst Upgrades and Downgrades

Separately, BTIG Research lowered shares of Alpha Teknova from a “buy” rating to a “neutral” rating in a research report on Tuesday, March 12th.

Alpha Teknova Stock Down 1.8 %

The stock has a market capitalization of $77.56 million, a PE ratio of -1.64 and a beta of 0.39. The company has a current ratio of 5.14, a quick ratio of 3.84 and a debt-to-equity ratio of 0.15. The company’s 50-day moving average is $2.50 and its 200 day moving average is $2.73.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings data on Monday, March 11th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Alpha Teknova had a negative net margin of 100.26% and a negative return on equity of 38.12%. The firm had revenue of $7.87 million during the quarter, compared to analyst estimates of $8.20 million. As a group, analysts anticipate that Alpha Teknova, Inc. will post -0.66 EPS for the current year.

Institutional Trading of Alpha Teknova

Several institutional investors and hedge funds have recently bought and sold shares of TKNO. Fielder Capital Group LLC purchased a new position in shares of Alpha Teknova during the 4th quarter valued at approximately $156,000. Conestoga Capital Advisors LLC increased its holdings in shares of Alpha Teknova by 4.1% during the 4th quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock valued at $923,000 after purchasing an additional 9,800 shares in the last quarter. Finally, Platinum Investment Management Ltd. increased its holdings in shares of Alpha Teknova by 169.9% during the 3rd quarter. Platinum Investment Management Ltd. now owns 834,529 shares of the company’s stock valued at $2,328,000 after purchasing an additional 525,351 shares in the last quarter. 13.81% of the stock is currently owned by institutional investors and hedge funds.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.